期刊文献+

乳腺癌neu癌基因扩增及蛋白表达研究

AMPLIFICATION AND EXPRESSION OF NEU ONCOGENE IN BREAST CANCERS
暂未订购
导出
摘要 目的 观察乳腺癌中neu癌基因扩增和蛋白表达及与临床病理特征的关系。方法 应用免疫组化及点杂交技术对 90例乳腺肿瘤neu癌基因扩增及蛋白表达进行研究 ,结果 乳腺癌中neu蛋白表达率为 38% ,导管内乳头状瘤及正常乳腺组织均为阴性 ;neu表达与乳腺癌组织学分级 (P <0 .0 1)及淋巴结转移呈正相关 (P <0 .0 1) ,与雌激素受体状态呈负相关 (P <0 .0 1) ;neu癌基因扩增率为 36% ,与乳腺癌组织学分级呈正相关 (P <0 .0 1) ,与雌激素受体状态呈负相关。结论 该基因的扩增及表达与乳腺上皮细胞的恶性转化及淋巴结转移密切相关 ,因此 。 Objective To investigate the correlations of amplification and expression of neu oncogene with clinicopathologic features of breast cancers.Methods Amplification and expression of neu oncogene were detected in 90 cases of breast tumors using immunohistochemistry and isotope Dot blot hybridisation.Results 38% malignant cases were positive staining.while benign cases negative.Neu expressions were positively associated with tumors grades( P <0.01)and lymph node metastasis( P <0.01),but negatively with ER status( P <0.01).Amplifications of neu were found in 36% breast cancers and positively associated with tumors grades( P <0.01),but negatively with ER status.Conclusion The alterations of neu oncogene were significantly associated with cancer transformation fo mammary epithelium and lymph node metastasis.Hence,Dedtecting neu oncogene might be a significant index in evaluation of biologic behavior and prognosis of breast cancers.
出处 《济宁医学院学报》 2001年第1期1-3,共3页 Journal of Jining Medical University
基金 卫生部科学基金!(96135 4) 卫生厅资助课题!(96CEAI)
关键词 乳腺癌 NEU基因 基因扩增 基因表达 生物学行为 预后 breast cancer neu oncogene amplification expression
  • 相关文献

参考文献8

  • 1Horiguchi J, Iino Y, Takei H, et al. Prognostic significance of c - erbB - 2 expression in invasive ductal carcinoma of the breast. JpnJ Clin Oncol.1995,25(4): 119
  • 2崔文,范连杰,孔灵玲,王旭,高继发,田德明,曹慧玲,梁桂华,张波.甲状腺癌HER-2/neu癌蛋白和mRNA表达的研究[J].中国肿瘤,2000,9(11):526-528. 被引量:5
  • 3Tagliabue E, Menard S, Robertson JF, et al. c - erbB - 2 expression in primary breast cancer. Int J Binl Markers. 1999,14( 1 ): 16
  • 4Gullick WJ, Love SB, Wright C, et al. C - erbb - 2 proteinoverexpression in breast cancer is a risk factor in patient with involved and uninvolvde lymph node. Br J Cancer, 1991,63:434
  • 5Molland JG, Barraclongh BH, Gebski V, et al. prognostic significance of c - erbB - 2 oncogene in axillary node - negative breast cancer. Aust N Z J Surg, 1996,66(2) :64
  • 6Torregrosa D, Bolufer P, Liuch A, et al. Prognostic significance of c - erbB- 2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status. Clin Chim Acta, 1997,27; 262 ( 1 - 2 ): 99
  • 7Okuyama N,Hatano Y,Park Y, et al. Quantitatinn of c - erbB - 2 gene amplification in breast cancer tissue by competitive PCR. Tumour Biol,1999,20(3): 153
  • 8Farabegoli F, Ceccarelli C, Santini D, et al. c - erbB - 2 over - expression in amplified and non - amplified breast carcinoma samples. Int J Cancer,1999,21:84(3) :273

二级参考文献2

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部